Decreased Drug Accumulation and Increased Tolerance to DNA Damage in Tumor Cells with a Low Level of Cisplatin Resistance

This publication has 15 references indexed in Scilit:

• Structure and Function of the p53 Tumor Suppressor Gene: Clues for Rational Cancer Therapeutic Strategies
  JNCI Journal of the National Cancer Institute, 1996
• DNA Repair: Enzymatic Mechanisms and Relevance to Drug Response
  JNCI Journal of the National Cancer Institute, 1996
• Effects of Cisplatin on Cell Cycle Kinetics, Morphological Change, and Cleavage Pattern of DNA in Two Human Ovarian Carcinoma Cell Lines
  Oncology, 1996
• Differential formation and enhanced removal of specific cisplatin–DNA adducts in two cisplatin-selected resistant human testicular teratoma sublines
  Anti-Cancer Drugs, 1994
• Signaling and drug sensitivity
  Cancer and Metastasis Reviews, 1994
• Short-termcis-diamminedichloroplatinum(II) accumulation in sensitive and resistant human ovarian carcinoma cells
  Cancer Chemotherapy and Pharmacology, 1990
• Enhanced DNA repair as a mechanism of resistance to cis-diamminedichloroplatinum(II)
  Biochemistry, 1988
• Cisplatin
  Annals of Internal Medicine, 1984
• A sensitive method to measure physical and chemical carcinogen-induced “unscheduled DNA synthesis” in rapidly dividing eukaryotic cells
  Experimental Cell Research, 1974
• Tissue sulfhydryl groups
  Archives of Biochemistry and Biophysics, 1959